The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar
SYDNEY, AU, Feb 15, 2023 ̵ […]
Fuel Cell Bus Trials on the BRT Hikoboshi Line
TOKYO, Feb 8, 2023 – (JC […]
Asia Pacific Cell & Gene Research: Novotech is Growing 50% Faster than ROW
SYDNEY, AU, Feb 3, 2023 – […]
Novotech is Gold Sponsor at Biotech Showcase 2023
SYDNEY, AU, Dec 20, 2022 ̵ […]
Data Shows 50% of New Trials Have Sites in Asia Pacific
SYDNEY, AU, Dec 15, 2022 ̵ […]
Novotech Chairs BioCentury Summit Workshop on How to Build and Finance an East-West MRCT Strategy
SYDNEY, AU, Nov 11, 2022 ̵ […]
Novotech Selected as Scrip Awards Finalist for Best Full-Service CRO
SYDNEY, AU, Oct 7, 2022 – […]
Novotech presented with Cell & Gene Excellence Award 2022 at 6th Cell & Gene Therapy World Asia Conference
SYDNEY, AU, Sep 15, 2022 ̵ […]
Novotech at ESMO Congress 2022 – New Data Shows 100% Oncology Trials Growth in APAC
SYDNEY, Sep 5, 2022 – (A […]
APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report
SYDNEY, Sep 2, 2022 – (A […]
Novotech Receives “Best Biologics CRO Award 2022” at Korea Bioprocessing Excellence Awards 2022
SEOUL, S.KOREA, Jun 29, 2022 & […]
Novotech Receives CRO Leadership Award for Exceeding Customer Expectations
CHICAGO, IL, Jun 23, 2022 R […]
Novotech’s APAC and USA Leadership Teams at BIO 2022
SAN DIEGO, CA, Jun 14, 2022 &# […]
Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China
SYDNEY, Jun 6, 2022 – (A […]
Fujitsu, NTT DOCOMO and NTT to start joint trials towards practical applications for 6G
TOKYO, Jun 6, 2022 – (JC […]
Novotech Sponsors Pre-ASCO China Summit: Go/No Go Decisions Based on Early Phase Oncology Trials
SYDNEY, May 12, 2022 – ( […]
Avance Clinical Finalist for Informa Pharma Intelligence Awards 2022 – Best Contract Research Organization in APAC
ADELAIDE, AUS, Apr 19, 2022 &# […]